The drug fondaparinux sodium is a generic version of Arixtra drug and has been approved by US and Europe for treating deep vein thrombosis and pulmonary embolism.

An anti-coagulant drug, fondaparinux sodium is generic version of Arixtra drug and has been approved by US and Europe for treating deep vein thrombosis and pulmonary embolism, it added.
Alchemia markets Fondaparinux in the US and other markets through partner Dr. Reddy Laboratories, the statement added.
Source-IANS